Vanguard Capital Management
RNXT icon

Vanguard Capital Management’s RenovoRx RNXT Stock Holding History

Vanguard Capital Management’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
1,443,742
-3,435
-0.2% -$3.12K ﹤0.01% 3518
2026
Q1 		$1.46M Buy
+1,447,177
New +$1.4M ﹤0.01% 3464

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Vanguard Capital Management's RNXT Position: Q2 2026 in Review

Vanguard Capital Management reduced its RenovoRx (RNXT) stake by 0.24% in Q2 2026, selling an estimated $3.12K and leaving 1,443,742 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3518.

Vanguard Capital Management first reported a position in RNXT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.46M in Q1 2026. 29 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Vanguard Capital Management held 1,443,742 shares of RenovoRx worth $1.41M as of Q2 2026.
  • Vanguard Capital Management sold 3,435 RenovoRx shares in Q2 2026, an estimated $3.12K.
  • RenovoRx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3518 holding.
  • Vanguard Capital Management first reported a position in RenovoRx in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's RenovoRx position peaked at $1.46M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.